As previously shown, CDKN2A deletion reprograms lipid metabolism, leading to ferroptosis in GBM cells [5], and Rho family GTPase 1 promotes ferroptosis in GBM cells through p53 [46]. Here, CDKN2A is linked to glioblastoma.